UpdatesPress Release
Sharda Cropchem posted strong Q2/H1 FY26 results: Revenue +20%/23%, PAT +75%/212%. Volume-driven growth, led by Agrochemicals.
Sharda Cropchem LimitedSHARDACROP · Filed with the exchange
Margins expanded significantly, with EBITDA soaring +71%/69%. The company remains debt-free, maintaining robust cash reserves and a strong product registration pipeline.
No comments yet. Be the first.